+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
BOROSCI

Borosil Scientific Share Price

₹138.92 -1.82 (-1.29%)
43.75% Gain from 52W Low

06 Aug, 2026 3:31 PM (IST)

Borosil Scientific live price: ₹138.92. It opened at ₹141 vs previous close ₹141; intraday high/low: ₹141/₹138. The 50 & 200 DMA stand at ₹150.70/₹137.10.

Borosil Scientific Performance

  • Today's Low
  • ₹138
  • Today's High
  • ₹141
  • 52 Week Low
  • ₹97
  • 52 Week High
  • ₹181
  • Open Price₹141
  • Previous Close₹141
  • Volume95,664
  • 50 DMA₹150.70
  • 100 DMA₹142.20
  • 200 DMA₹137.10

Borosil Scientific Chart

Investment Returns

  • Over 1 Month -16.54%
  • Over 3 Month + 18.57%
  • Over 6 Month + 31.3%
  • Over 1 Year -10.69%

Smart Investing Starts Here Start SIP with Borosil Scientific for Steady Growth!

Invest Now

Borosil Scientific Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 28.6
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 1,236
  • P/B Ratio
  • 2.8
  • Average True Range
  • 6.7
  • EPS
  • 4.9
  • Dividend Yield
  • 0
  • MACD Signal
  • -3.1
  • RSI
  • 29.98
  • MFI
  • 16.29

Latest Stock News Updates

Borosil Scientific Ltd - 544184 - Announcement under Regulation 30 (LODR)-Investor Presentation

Investor Presentation on Company''s performance - Q1-FY 2027

Q1FY27 Quarterly Result Announced for Borosil Scientific Ltd.

<h3><span style="font-size:16px;"><strong>Containers & Packaging company Borosil Scientific announced Q1FY27 results</strong></span></h3> <p _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Consolidated Financial Highlights:</strong></p> <ul> <li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Revenue from Operations:</strong> The consolidated revenue for Q1FY27 stood at Rs 10,675.23 lakh, representing a growth of 11.23% on a YoY basis compared to Rs 9,597.64 lakh in Q1FY26 and a decline of 25.43% on a QoQ basis compared to Rs 14,316.87 lakh in Q4FY26.</li> <li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Total Income:</strong> The total income for Q1FY27 was Rs 10,941.87 lakh, reflecting an increase of 10.64% over Rs 9,889.44 lakh in Q1FY26 and a decrease of 24.66% over Rs 14,523.14 lakh in Q4FY26.</li> <li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Profit Before Tax (PBT):</strong> The group reported a PBT of Rs 598.07 lakh in Q1FY27, marking a turnaround to profitability from a loss of Rs 408.20 lakh in Q1FY26. However, PBT declined by 79.48% compared to Rs 2,914.60 lakh in Q4FY26.</li> <li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Net Profit for the Period:</strong> Consolidated net profit reached Rs 435.51 lakh in Q1FY27, as against a loss of Rs 420.96 lakh in Q1FY26. On a QoQ basis, the profit decreased by 84.02% from Rs 2,724.59 lakh in Q4FY26.</li> <li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Total Comprehensive Income:</strong> This parameter stood at Rs 430.29 lakh in Q1FY27, compared to a loss of Rs 422.46 lakh in Q1FY26 and a profit of Rs 2,722.47 lakh in Q4FY26.</li> </ul> <p _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Standalone Financial Highlights:</strong></p> <ul> <li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Revenue from Operations:</strong> Standalone revenue for Q1FY27 was Rs 9,989.68 lakh, an increase of 12.23% YoY from Rs 8,900.95 lakh in Q1FY26 and a decrease of 24.27% QoQ from Rs 13,191.95 lakh in Q4FY26.</li> <li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Total Income:</strong> Standalone total income stood at Rs 10,269.30 lakh in Q1FY27, up 11.54% from Rs 9,206.99 lakh in Q1FY26 and down 23.39% from Rs 13,404.22 lakh in Q4FY26.</li> <li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Profit Before Tax (PBT):</strong> For Q1FY27, PBT was Rs 931.11 lakh, representing a significant jump of 1,305.45% YoY from Rs 66.25 lakh in Q1FY26, and a decline of 67.72% QoQ from Rs 2,884.77 lakh in Q4FY26.</li> <li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Net Profit for the Period:</strong> Net profit stood at Rs 684.35 lakh in Q1FY27, marking an increase of 1,395.52% compared to Rs 45.76 lakh in Q1FY26, but a decline of 68.22% compared to Rs 2,153.57 lakh in Q4FY26.</li> <li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Earnings Per Share (EPS):</strong> Basic and Diluted EPS (not annualised) was Rs 0.77 for Q1FY27, compared to Rs 0.05 in Q1FY26 and Rs 2.42 in Q4FY26.</li> </ul> <p _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Business Highlights and Segment Performance:</strong></p> <ul _ngcontent-ng-c3377174747=""> <li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Segment-wise Performance:</strong> <ul> <li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Scientific - Laboratory Glass & equipment and Process System:</strong> Revenue was Rs 6,668.11 lakh with a segment result (profit before tax and finance cost) of Rs 935.54 lakh for Q1FY27.</li> <li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Glassware:</strong> This segment recorded revenue of Rs 3,836.21 lakh and a segment profit of Rs 19.00 lakh for Q1FY27.</li> <li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Others:</strong> Revenue stood at Rs 170.91 lakh with a segment profit of Rs 42.97 lakh for Q1FY27.</li> </ul> </li> <li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">ESOP Modifications:</strong> The Board approved amendments to ESOP schemes (SP-ESOP 2023 and BSL ESOS) to allow for secondary acquisition through the Trust route and to increase the maximum discount limit for grant of new options from 10% to 20% for the BSL ESOS.</li> <li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Goel Scientific Glass Works Limited:</strong> The unaudited consolidated results include the performance of this subsidiary, which reflected a total revenue of Rs 762.82 lakh and a total net loss after tax of Rs 236.18 lakh for Q1FY27.</li> </ul> <p><a class="lb" href="/get-document/post/pdf/5762002/" target="_blank">Result PDF</a></p>

Borosil Scientific Ltd - 544184 - Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2026

Outcome of Board Meeting

Borosil Scientific Financials

Borosil Scientific Technicals

EMA & SMA

Current Price
₹138.92
-1.82 (-1.29%)
pointer
  • Bearish Moving Average 12
  • Bullish Moving Average 4
  • 20 Day
  • ₹153.00
  • 50 Day
  • ₹150.70
  • 100 Day
  • ₹142.20
  • 200 Day
  • ₹137.10

Resistance and Support

139.41 Pivot Speed
  • R3 143.40
  • R2 142.20
  • R1 140.60
  • S1 137.70
  • S2 136.50
  • S3 134.90

Borosil Scientific Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-03 Quarterly Results
2026-05-20 Audited Results & Fund Raising
2026-02-11 Quarterly Results
2025-11-06 Quarterly Results
2025-08-11 Quarterly Results

Borosil Scientific Shareholding Pattern

68.27%
31.22%
0.25%
0.23%
0.01%

About Borosil Scientific

Borosil Scientific is engaged in the business of Scientific Laboratory Glassware, Laboratory Equipments, Pharmaceuticals Primary Packaging (Ampoules and Vials), Process System and Domestic Glassware Items.(Source : 202503 Annual Report Page No: 47) View More
  • NSE Symbol
  • BOROSCI
  • BSE Symbol
  • 544184
  • ISIN
  • INE02L001032

Similar Stocks to Borosil Scientific

Borosil Scientific FAQs

Borosil Scientific share price is ₹138 As on 06 August, 2026 | 22:01

The Market Cap of Borosil Scientific is ₹1235.7 Cr As on 06 August, 2026 | 22:01

The P/E ratio of Borosil Scientific is 28.6 As on 06 August, 2026 | 22:01

The PB ratio of Borosil Scientific is 2.8 As on 06 August, 2026 | 22:01

The 52 week High & Low of Borosil Scientific is ₹180.8/₹96.6 respectively As on 06 August, 2026 | 22:01

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23